Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Galactosylceramides | 8 | 2019 | 11 | 2.750 |
Why?
|
Furans | 8 | 2023 | 38 | 2.370 |
Why?
|
Disaccharides | 7 | 2022 | 10 | 1.940 |
Why?
|
Glycosides | 10 | 2017 | 21 | 1.670 |
Why?
|
Inositol | 3 | 2022 | 21 | 1.550 |
Why?
|
Acetogenins | 5 | 2023 | 7 | 1.290 |
Why?
|
Monosaccharides | 3 | 2017 | 11 | 1.140 |
Why?
|
Antineoplastic Agents | 5 | 2022 | 803 | 1.130 |
Why?
|
Arabinose | 2 | 2016 | 3 | 1.110 |
Why?
|
Xylose | 2 | 2016 | 11 | 1.110 |
Why?
|
Galactosides | 3 | 2015 | 11 | 1.030 |
Why?
|
Alkenes | 6 | 2022 | 15 | 1.020 |
Why?
|
Ethers | 4 | 2022 | 20 | 1.000 |
Why?
|
Adjuvants, Immunologic | 2 | 2017 | 107 | 1.000 |
Why?
|
Spiro Compounds | 3 | 2009 | 12 | 0.970 |
Why?
|
Prostatic Neoplasms | 3 | 2023 | 935 | 0.950 |
Why?
|
Carbohydrates | 3 | 2023 | 29 | 0.890 |
Why?
|
Prodrugs | 1 | 2023 | 24 | 0.880 |
Why?
|
Molecular Structure | 12 | 2016 | 492 | 0.870 |
Why?
|
Carbasugars | 1 | 2022 | 1 | 0.850 |
Why?
|
Fluorine | 2 | 2015 | 16 | 0.820 |
Why?
|
Cyclization | 7 | 2022 | 48 | 0.740 |
Why?
|
Stereoisomerism | 8 | 2015 | 167 | 0.690 |
Why?
|
HIV Envelope Protein gp120 | 3 | 2011 | 55 | 0.670 |
Why?
|
Tin Compounds | 1 | 2018 | 3 | 0.650 |
Why?
|
Hydrocarbons, Iodinated | 2 | 2008 | 2 | 0.630 |
Why?
|
Ceramides | 1 | 2017 | 42 | 0.570 |
Why?
|
Cholestanol | 1 | 2016 | 1 | 0.560 |
Why?
|
Lactones | 3 | 2005 | 22 | 0.560 |
Why?
|
Glucosides | 1 | 2016 | 16 | 0.550 |
Why?
|
Mannose | 3 | 2022 | 25 | 0.530 |
Why?
|
Proline | 1 | 2015 | 43 | 0.520 |
Why?
|
Acetamides | 1 | 2015 | 11 | 0.510 |
Why?
|
Carbon | 1 | 2015 | 105 | 0.490 |
Why?
|
Glycosphingolipids | 1 | 2014 | 5 | 0.480 |
Why?
|
Nitrogen | 1 | 2014 | 71 | 0.440 |
Why?
|
Thiophenes | 2 | 2023 | 31 | 0.430 |
Why?
|
Pyruvate Dehydrogenase (Lipoamide)-Phosphatase | 1 | 2010 | 2 | 0.360 |
Why?
|
Monensin | 1 | 2009 | 4 | 0.360 |
Why?
|
Antiviral Agents | 1 | 2011 | 157 | 0.350 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2010 | 46 | 0.350 |
Why?
|
Cell Line, Tumor | 3 | 2023 | 2231 | 0.340 |
Why?
|
Carbohydrate Conformation | 5 | 2015 | 14 | 0.340 |
Why?
|
Structure-Activity Relationship | 5 | 2013 | 409 | 0.330 |
Why?
|
Cycloparaffins | 1 | 2008 | 1 | 0.320 |
Why?
|
Anthraquinones | 1 | 2008 | 9 | 0.320 |
Why?
|
Molecular Conformation | 3 | 2016 | 152 | 0.310 |
Why?
|
Marine Toxins | 1 | 2007 | 13 | 0.310 |
Why?
|
Galactose | 2 | 2007 | 8 | 0.310 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2008 | 132 | 0.290 |
Why?
|
Models, Molecular | 6 | 2019 | 808 | 0.280 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2006 | 21 | 0.280 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 352 | 0.280 |
Why?
|
Pyrans | 1 | 2005 | 10 | 0.260 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2005 | 34 | 0.260 |
Why?
|
Magnetic Resonance Spectroscopy | 7 | 2009 | 289 | 0.260 |
Why?
|
Catalysis | 3 | 2015 | 179 | 0.260 |
Why?
|
Oligosaccharides | 2 | 2007 | 24 | 0.250 |
Why?
|
Fatty Alcohols | 1 | 2004 | 7 | 0.240 |
Why?
|
Artemisinins | 1 | 2004 | 20 | 0.240 |
Why?
|
Amines | 1 | 2004 | 39 | 0.240 |
Why?
|
Ethers, Cyclic | 1 | 2003 | 5 | 0.230 |
Why?
|
Antigens, Surface | 1 | 2023 | 43 | 0.220 |
Why?
|
Trichothecenes | 1 | 2022 | 1 | 0.220 |
Why?
|
4-Butyrolactone | 1 | 2022 | 11 | 0.220 |
Why?
|
Galactosamine | 1 | 2022 | 4 | 0.210 |
Why?
|
Swainsonine | 1 | 2001 | 2 | 0.200 |
Why?
|
Indolizines | 1 | 2001 | 4 | 0.200 |
Why?
|
Protein Binding | 3 | 2019 | 972 | 0.180 |
Why?
|
Receptors, IgG | 1 | 2000 | 50 | 0.180 |
Why?
|
Mannosides | 1 | 2019 | 3 | 0.180 |
Why?
|
Concanavalin A | 1 | 2019 | 10 | 0.180 |
Why?
|
Carbohydrate Sequence | 2 | 2015 | 22 | 0.170 |
Why?
|
Microarray Analysis | 1 | 2019 | 61 | 0.170 |
Why?
|
Sphingosine | 1 | 2019 | 21 | 0.170 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 121 | 0.170 |
Why?
|
Oxidation-Reduction | 2 | 2016 | 431 | 0.170 |
Why?
|
Antigen Presentation | 1 | 2019 | 54 | 0.170 |
Why?
|
Halogenation | 2 | 2009 | 19 | 0.170 |
Why?
|
Myelin Sheath | 1 | 2019 | 48 | 0.170 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 54 | 0.160 |
Why?
|
HIV Infections | 1 | 2011 | 2303 | 0.150 |
Why?
|
Humans | 7 | 2023 | 37093 | 0.140 |
Why?
|
Glycolipids | 2 | 2019 | 9 | 0.140 |
Why?
|
Male | 3 | 2023 | 20025 | 0.140 |
Why?
|
Macrophages | 1 | 2019 | 439 | 0.130 |
Why?
|
Aldehydes | 1 | 2015 | 69 | 0.130 |
Why?
|
Mice | 3 | 2019 | 5913 | 0.130 |
Why?
|
Crystallography, X-Ray | 1 | 2015 | 265 | 0.130 |
Why?
|
Hela Cells | 2 | 2013 | 366 | 0.120 |
Why?
|
Jurkat Cells | 1 | 2013 | 79 | 0.110 |
Why?
|
Scattering, Radiation | 1 | 2013 | 47 | 0.110 |
Why?
|
Cytokines | 1 | 2017 | 602 | 0.110 |
Why?
|
Light | 1 | 2013 | 187 | 0.110 |
Why?
|
Esters | 1 | 2011 | 28 | 0.100 |
Why?
|
Micelles | 1 | 2011 | 32 | 0.100 |
Why?
|
HIV-1 | 2 | 2008 | 706 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 112 | 0.100 |
Why?
|
Surface Properties | 1 | 2011 | 130 | 0.100 |
Why?
|
HIV | 1 | 2011 | 98 | 0.090 |
Why?
|
Receptors, CXCR4 | 1 | 2011 | 69 | 0.090 |
Why?
|
Fatty Acids | 1 | 2011 | 127 | 0.090 |
Why?
|
Cell Survival | 1 | 2013 | 864 | 0.090 |
Why?
|
Animals | 3 | 2019 | 15081 | 0.090 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2008 | 8 | 0.080 |
Why?
|
Enzyme Activation | 1 | 2010 | 444 | 0.080 |
Why?
|
Peptides | 1 | 2011 | 320 | 0.080 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2008 | 113 | 0.080 |
Why?
|
Virus Internalization | 1 | 2008 | 28 | 0.080 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2007 | 14 | 0.070 |
Why?
|
Cell Line | 1 | 2011 | 1354 | 0.070 |
Why?
|
Indicators and Reagents | 1 | 2007 | 58 | 0.070 |
Why?
|
P-Selectin | 1 | 2007 | 7 | 0.070 |
Why?
|
Tumor Cells, Cultured | 1 | 2008 | 502 | 0.070 |
Why?
|
Acids | 1 | 2007 | 18 | 0.070 |
Why?
|
Cyclohexanes | 1 | 2005 | 30 | 0.070 |
Why?
|
Sesquiterpenes | 1 | 2005 | 32 | 0.060 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 132 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2008 | 420 | 0.060 |
Why?
|
Rats | 1 | 2010 | 3483 | 0.050 |
Why?
|
Glycoside Hydrolases | 1 | 2001 | 6 | 0.050 |
Why?
|
Amination | 1 | 2001 | 5 | 0.050 |
Why?
|
Alkylation | 1 | 2001 | 11 | 0.050 |
Why?
|
Spectrophotometry, Infrared | 1 | 2001 | 37 | 0.050 |
Why?
|
Spectrometry, Mass, Fast Atom Bombardment | 1 | 2000 | 7 | 0.050 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2019 | 22 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2001 | 260 | 0.040 |
Why?
|
Fluorescence | 1 | 2019 | 121 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2019 | 53 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2001 | 433 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2019 | 181 | 0.040 |
Why?
|
Autoantigens | 1 | 2019 | 81 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2000 | 1568 | 0.040 |
Why?
|
Solanaceous Alkaloids | 1 | 1995 | 1 | 0.030 |
Why?
|
Phytosterols | 1 | 1995 | 3 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 1609 | 0.030 |
Why?
|
Membrane Fusion | 1 | 2008 | 11 | 0.020 |
Why?
|
Molecular Mimicry | 1 | 2007 | 16 | 0.020 |
Why?
|
Reference Standards | 1 | 2007 | 52 | 0.020 |
Why?
|
Models, Chemical | 1 | 2007 | 207 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 562 | 0.020 |
Why?
|
Computer Simulation | 1 | 2007 | 362 | 0.020 |
Why?
|
Time Factors | 1 | 2007 | 1742 | 0.010 |
Why?
|
Female | 1 | 2019 | 20969 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1995 | 37 | 0.010 |
Why?
|
Plant Leaves | 1 | 1995 | 124 | 0.010 |
Why?
|